Skip to main
PRVL
PRVL logo

Prevail Therapeutics Inc (PRVL)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy PRVL Stock

About Prevail Therapeutics Inc (PRVL)

Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY.
Market cap$787.7M
Today's volume
Revenue (TTM)
Avg. daily volume545.53K
EBITDA (TTM)
Open
Price / earnings ratio-10.03x
Today's range
Debt / equity
52 week range$9.02 - $23.35
5 year debt / equity19.59x
Beta (LTM)1.05x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 13, 2020
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for PRVL stock is $787.71M

The current P/E ratio for PRVL stock is -10.03

The 52-week high for PRVL stock is $23.35. The current PRVL stock price $undefined is 100.00% below its 52-week high

The 52-week low for PRVL stock is $9.02. The current PRVL stock price $undefined has increased 100.00% from its 52-week low

No, the PRVL stock does not pay dividends to its shareholders

How to buy PRVL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in PRVL stock

    Navigate to the Explore page. Then, type PRVL into the search bar. When you see PRVL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased PRVL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Prevail Therapeutics Inc Stock Earnings

The value each PRVL share was expected to gain vs. the value that each PRVL share actually gained.

PRVL (PRVL) reported Q2 2020 earnings per share (EPS) of -$0.66, missing estimates of -$0.59 by 11.86%. In the same quarter last year, PRVL's earnings per share (EPS) was $0. PRVL is expected to release next earnings on 11/13/2020, with an earnings per share (EPS) estimate of $0.

Buy PRVL Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.